2020
DOI: 10.31080/asmi.2020.03.0699
|View full text |Cite
|
Sign up to set email alerts
|

A Venture to Discover the Treatment of Coronavirus Disease 2019 (COVID 19): SARS-CoV-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 0 publications
2
9
0
Order By: Relevance
“…Validation test conducted on dry syrups Clavamox® showed that the spectrophotometric method of derivatives meet the requirements validation, which includes parameters of accuracy and precision. Pharmacokinetic parameters of amoxicillin and clavulanic acid in formulations used in this study were similar to previously published data [17,18] . Furthermore, the new formulations of Co-Amoxiclav® (312 and 156 mg/5 ml) suspensions is bioequivalent to the reference formulation (Augmentin® 312 mg/5 ml) manufactured by Beecham, England.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Validation test conducted on dry syrups Clavamox® showed that the spectrophotometric method of derivatives meet the requirements validation, which includes parameters of accuracy and precision. Pharmacokinetic parameters of amoxicillin and clavulanic acid in formulations used in this study were similar to previously published data [17,18] . Furthermore, the new formulations of Co-Amoxiclav® (312 and 156 mg/5 ml) suspensions is bioequivalent to the reference formulation (Augmentin® 312 mg/5 ml) manufactured by Beecham, England.…”
Section: Discussionsupporting
confidence: 88%
“…It was first introduced into clinical medicine in Europe in 1981 and in United States in 1984. 17 Since its release, combination of amoxicillin and clavulanate has been extensively used in patients of all ages including infants, children and adults. 18 The highly desirable antibacterial spectrum of the drug combined with its favorable pharmacokinetic and safety profiles underscore its rapid acceptance as one of the most commonly prescribed antibiotics.…”
Section: Introductionmentioning
confidence: 99%
“…20 mg/kg of cefuroxime axetil suspension is similar to a 500 mg tablet for adults. Our kids on 15 or 20 mg/kg cefuroxime axetil suspension had a Cmax similar to those on broken tablets in 85% sucrose (27) . Cmax and AUC rose correspondingly over 10-20 mg/kg.…”
Section: Pharmacokinetics Of Cefueoxime Axetilsupporting
confidence: 51%
“…When development and stability statistics demonstrate container/closure extractables are below safe levels, this test can be omitted. [19,20] Reevaluate if container/closure or formulation changes.…”
Section: Gradientmentioning
confidence: 99%
“…Validate dissolving techniques using pharmacopoeial or non-pharmacopoeial equipment/circumstances. [19] Immediate-release formulations have single-point measurements. Multiple-point sampling is required for modified-release formulations.…”
Section: Gradientmentioning
confidence: 99%